Previous Close | $304.10 |
Intrinsic Value | $725.84 |
Upside potential | +139% |
Data is not available at this time.
UnitedHealth Group Incorporated operates as a diversified healthcare company, primarily through its UnitedHealthcare insurance segment and Optum health services platform. The company generates revenue through health insurance premiums, pharmacy benefit management, data analytics, and technology-enabled healthcare services. As the largest health insurer in the U.S. by revenue, UNH holds a dominant position in managed care, serving over 50 million members. Its Optum segment provides integrated care delivery, pharmacy care services, and health IT solutions, creating a vertically integrated model that differentiates it from peers. The company's scale and diversified offerings allow it to navigate regulatory complexities while capitalizing on trends toward value-based care and digital health innovation. UNH maintains competitive advantages through its vast provider networks, data analytics capabilities, and strategic acquisitions that expand its service offerings and geographic reach.
UnitedHealth reported $400.3 billion in revenue for FY 2024, demonstrating its massive scale in the healthcare sector. Net income stood at $14.4 billion, with diluted EPS of $15.51, reflecting efficient operations despite industry margin pressures. Operating cash flow of $24.2 billion and capital expenditures of $3.5 billion indicate strong cash generation capabilities and disciplined reinvestment in the business.
The company demonstrates robust earnings power, with its diversified model supporting consistent profitability across economic cycles. UNH's capital efficiency is evident in its ability to generate substantial operating cash flow while maintaining investments in growth areas like Optum Health and Optum Insight. The balance between insurance operations and health services creates multiple earnings streams that enhance overall returns.
UNH maintains a solid financial position with $25.3 billion in cash and equivalents against $76.9 billion in total debt. The company's leverage appears manageable given its strong cash flows and earnings stability. With 929 million shares outstanding, the capital structure supports both growth initiatives and shareholder returns through dividends and potential share repurchases.
UnitedHealth has demonstrated consistent growth through organic expansion and strategic acquisitions, particularly in its Optum segments. The company pays an annual dividend of $8.11 per share, reflecting a commitment to returning capital to shareholders while retaining sufficient funds for reinvestment. Future growth is expected to come from healthcare services expansion, technology integration, and international opportunities.
The market values UNH as a healthcare leader with defensive characteristics and growth potential. Current valuation multiples reflect expectations for continued earnings growth, margin stability, and successful execution of its integrated care strategy. Investors appear to price in UNH's ability to navigate regulatory changes and maintain its competitive position in evolving healthcare markets.
UnitedHealth's key advantages include its unmatched scale, diversified business model, and technology-driven healthcare solutions. The outlook remains positive as demographic trends and healthcare digitization create tailwinds. Potential risks include regulatory changes and integration challenges from acquisitions, but UNH's proven execution capability positions it well for long-term success in transforming healthcare delivery and payment systems.
Company 10-K filing, investor presentations
show cash flow forecast
Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
Revenue growth rate, % | NaN | |||||||||||||||||||||||||
Revenue, $ | NaN | |||||||||||||||||||||||||
Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
Total operating expenses, $m | NaN | |||||||||||||||||||||||||
Operating income, $m | NaN | |||||||||||||||||||||||||
EBITDA, $m | NaN | |||||||||||||||||||||||||
Interest expense (income), $m | NaN | |||||||||||||||||||||||||
Earnings before tax, $m | NaN | |||||||||||||||||||||||||
Tax expense, $m | NaN | |||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
Total assets, $m | NaN | |||||||||||||||||||||||||
Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
Average production assets, $m | NaN | |||||||||||||||||||||||||
Working capital, $m | NaN | |||||||||||||||||||||||||
Total debt, $m | NaN | |||||||||||||||||||||||||
Total liabilities, $m | NaN | |||||||||||||||||||||||||
Total equity, $m | NaN | |||||||||||||||||||||||||
Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
Funds from operations, $m | NaN | |||||||||||||||||||||||||
Change in working capital, $m | NaN | |||||||||||||||||||||||||
Cash from operations, $m | NaN | |||||||||||||||||||||||||
Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
New CAPEX, $m | NaN | |||||||||||||||||||||||||
Total CAPEX, $m | NaN | |||||||||||||||||||||||||
Free cash flow, $m | NaN | |||||||||||||||||||||||||
Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
Discount rate, % | NaN | |||||||||||||||||||||||||
PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
Current shareholders' claim on cash, % | NaN |